Global Health Ltd (MEDANTA) is currently trading at 1,138.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Global Health Limited (Medanta) operates as a leading private multi-specialty tertiary healthcare provider in North and Eastern India. With flagship hospitals in Gurugram, Lucknow, Patna, and others, they offer comprehensive medical services, especially excelling in cardiology and cardiac science, neurosciences, and oncology. In Q2 FY26, the company reported a total income growth of 15% year-over-year, showcasing robust financial progress. They also maintained strong EBITDA margins, signifying operational efficiency despite ongoing expansions. Medanta's new Noida facility marks a strategic expansion, contributing to future revenue streams. Initial operations have been promising, significantly enhancing their service capacity and regional presence, emphasizing their strategic growth potential. The expansion plans in Guwahati and Mumbai mark significant forward momentum, enhancing Medanta's geographical footprint and service capabilities. These initiatives are poised to strengthen their market position and patient outreach. Medanta focuses heavily on bringing advanced medical technology to its facilities. The new Noida hospital features cutting-edge diagnostic and treatment technologies, underpinning their commitment to providing high-quality healthcare services.

Over the past 52 weeks, Global Health Ltd has traded between a low of ₹1,015.00 and a high of ₹1,455.85. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Global Health Ltd has a market capitalization of approximately 30,701.24. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Global Health Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 54.01 and operates in the Healthcare sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

You can buy shares of Global Health Ltd (MEDANTA) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.

Based on its market capitalization of 30,701.24 Cr, Global Health Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Global Health Ltd operates in the Healthcare sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Global Health Ltd is 54.01. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Global Health Ltd currently does not pay dividends. Companies that do not pay dividends often reinvest profits to support business growth or strengthen operations.

Key risks associated with Global Health Ltd include sector-specific challenges in the Healthcare industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.